发明名称 |
Method of administration of IGF-I |
摘要 |
Disclosed is the use of insulin-like growth factor-I (IGF-I) in the preparation of a medicament for administering to a mammal so as to sustain its biological response in the treatment of a chronic disorder in the mammal wherein the medicament is formulated for administration according to a dosing regime providing IGF-I to the mammal to provide an exposure to IGF-I that is continuous or at least once a day consecutively over a period of days that provides the maximum biological response in the mammal, then discontinuing said administration by means of a continual lack of treatment or a lack of treatment for consecutive days over a period of days equal to or less than the number of days during which the IGF-I was previously administered, then administering IGF-I to the mammal to provide an exposure to IGF-I that is continuous or at least once a day consecutively over a period of days that provides the maximum biological response in the mammal, then discontinuing said administration by means of a continual lack of treatment or a lack of treatment for consecutive days over a period of days equal to or less than the number of days during which the IGF-I was just previously administered, and repeating this pattern of administration and discontinuance of administration for as long as necessary to achieve or maintain sustained biological response in the mammal.
|
申请公布号 |
NZ539505(A) |
申请公布日期 |
2007.09.28 |
申请号 |
NZ19960539505 |
申请日期 |
1996.05.09 |
申请人 |
GENENTECH, INC.;WASHINGTON UNIVERSITY |
发明人 |
CLARK, ROSS G;GESUNDHEIT, NEIL;MILLER, STEVEN B;HAMMERMAN, MARC R |
分类号 |
(IPC1-7):A61K38/55;A61K38/30;A61P3/10;A61P9/00;A61P13/12 |
主分类号 |
(IPC1-7):A61K38/55 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|